NCT05012943 - The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) | Biotech Hunter

Enrollment

19,494

Participants

Timeline

Start Date

August 15, 2021

Primary Completion Date

January 18, 2023

Study Completion Date

January 18, 2023

Conditions

COVID-19 Vaccines

Interventions

BIOLOGICAL

ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine

OTHER

Placebo (normal saline)

Normal saline with the same volume as of ARCT-154

BIOLOGICAL

Astra Zeneca COVID-19 vaccine

Astra Zeneca COVID-19 vaccine (ChAdOx1 nCoV-19)

Trial Locations (3)

Pasteur Institute, Ho Chi Minh City

Hanoi Medical University, Hà Nội

Military Medical University, Hà Nội